According to market observers, shares of the company are available at a premium of ₹5 in the grey market today ...

as both drugs are gaining market share from traditional NSAIDS treatments. I reiterate a 'Buy' rating with a one-year target ...

Investors who placed bids for the issue will be able to find out the allotment status of their subscriptions on Monday.

The stock climbed 2.69% to Rs 827.45. Market cap of the firm rose to Rs 3.30 lakh crore in the current session.

The revenue from operations grew 32.7 per cent for the quarter under review to Rs 1,450.76 crore as compared to Rs 1093.2 ...

If you looked solely at its stock price, you might get the idea that Eli Lilly ... $1.2 billion of which was derived from ...

The company’s stock has more than tripled (up 232% ... "Despite great skepticism about our view of how to do this, the market ...

Asian stocks fell on Monday, led by a more than 2% drop in Hong Kong’s Hang Seng index, as China’s stimulus package ...